Assembly Biosciences Presents Clinical Data at Drug Formulation & Bioavailability Summit Showing Its Oral Gemicel(TM) Technology Achieves Targeted Delivery to the Lower GI Tract
January 27, 2016 07:30 ET
|
Assembly Biosciences, Inc.
PHILADELPHIA and INDIANAPOLIS, Jan. 27, 2016 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a biotechnology company developing treatments for infectious diseases including hepatitis B...
Assembly Biosciences Expands Senior Leadership Team
January 11, 2016 07:30 ET
|
Assembly Biosciences, Inc.
INDIANAPOLIS, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a biotechnology company developing curative treatments for infectious diseases including hepatitis B virus...
Assembly Biosciences to Present at Jefferies Microbiome Summit
December 16, 2015 07:30 ET
|
Assembly Biosciences, Inc.
INDIANAPOLIS, Dec. 16, 2015 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a biotechnology company developing curative treatments for infectious diseases including hepatitis B virus...
Clinical Study Shows Assembly Biosciences' Oral Gemicel™ Technology Can Achieve Targeted Delivery to the Lower GI Tract for Microbiome and Other Applications
December 09, 2015 07:00 ET
|
Assembly Biosciences, Inc.
—Assembly is Developing Curative Treatments for HBV, Resistant C. difficile Infections (CDI) and Other Infectious Diseases— —Expects to Initiate Phase lb Trial in 2016 Using Gemicel to Deliver...
Fecal transplant pills: Large-scale production begins
October 28, 2015 08:39 ET
|
OpenBiome
BOSTON, Oct. 28, 2015 (GLOBE NEWSWIRE) -- A new pill created by a team of MIT-trained researchers provides fecal transplant therapy without requiring the traditional, more invasive stool delivery...
C3 Jian Completes Second Phase 2 Clinical Trial of Anti-Cavity Drug
July 13, 2015 06:00 ET
|
C3 Jian, Inc.
LOS ANGELES, July 13, 2015 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a biotechnology company focused on reengineering the human microbiome to deliver novel healthcare products, announced it has preliminary...
Microbiome Revolution to Usher in 'Designer' Food, and Transform Well-Being
May 27, 2014 07:30 ET
|
Lux Research
BOSTON, MA--(Marketwired - May 27, 2014) - Over 100 trillion microbes live in and on the human body, predominantly in the digestive tract, comprising our "microbiome." Scientists are now starting to...